DE602006003617D1 - Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung. - Google Patents
Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung.Info
- Publication number
- DE602006003617D1 DE602006003617D1 DE602006003617T DE602006003617T DE602006003617D1 DE 602006003617 D1 DE602006003617 D1 DE 602006003617D1 DE 602006003617 T DE602006003617 T DE 602006003617T DE 602006003617 T DE602006003617 T DE 602006003617T DE 602006003617 D1 DE602006003617 D1 DE 602006003617D1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- compositions containing
- compositions
- containing levetiracetam
- levetiracetam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76210306P | 2006-01-24 | 2006-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006003617D1 true DE602006003617D1 (de) | 2008-12-24 |
Family
ID=36337638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006003617T Active DE602006003617D1 (de) | 2006-01-24 | 2006-03-07 | Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070172521A1 (de) |
EP (1) | EP1810676B1 (de) |
JP (1) | JP2009524658A (de) |
CN (1) | CN101360493A (de) |
AT (1) | ATE413875T1 (de) |
CA (1) | CA2637925A1 (de) |
DE (1) | DE602006003617D1 (de) |
DK (1) | DK1810676T3 (de) |
ES (1) | ES2317452T3 (de) |
IL (1) | IL193024A0 (de) |
PL (1) | PL1810676T3 (de) |
PT (1) | PT1810676E (de) |
WO (1) | WO2007086891A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009049642A1 (en) * | 2007-10-16 | 2009-04-23 | Pharmathen S.A. | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
US20120003307A1 (en) * | 2007-11-29 | 2012-01-05 | Ranbaxy Laboratories Limited | Levetiracetam controlled release composition |
WO2009135646A2 (en) * | 2008-05-05 | 2009-11-12 | Farmaprojects, Sa | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
US20100159009A1 (en) * | 2008-12-24 | 2010-06-24 | Zhongshui Yu | Controlled-release formulations |
US20100172979A1 (en) * | 2008-12-24 | 2010-07-08 | Zhongshui Yu | Controlled-release formulations |
CN104666272A (zh) | 2009-09-18 | 2015-06-03 | 赛诺菲 | 稳定性提高的(z)-2-氰基-3-羟基-丁-2-烯酸-(4’-三氟甲基苯基)-酰胺片剂制剂 |
CN101693017B (zh) * | 2009-10-28 | 2012-06-06 | 北京赛科药业有限责任公司 | 左乙拉西坦的药物组合物及其制备方法 |
EP2563340A2 (de) | 2010-04-26 | 2013-03-06 | Mahmut Bilgic | Wasserlösliche pharmazeutische zusammensetzung |
EP2387993B1 (de) * | 2010-05-21 | 2012-11-07 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Im Mund zerfallende Zolmitriptan-Tabletten und Herstellungsverfahren dafür |
CN102379857B (zh) * | 2011-05-30 | 2013-10-09 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦缓释药物组合物及其制备方法 |
CN102764254B (zh) * | 2012-05-16 | 2016-09-07 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦药物组合物及其制备方法 |
JP6630229B2 (ja) * | 2016-05-17 | 2020-01-15 | エルメッド株式会社 | レベチラセタム含有医薬組成物及びその製造方法 |
JP6422464B2 (ja) * | 2016-05-19 | 2018-11-14 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
JP6326114B2 (ja) * | 2016-11-01 | 2018-05-16 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4514389A (en) * | 1981-05-06 | 1985-04-30 | Kyowa Chemical Industry Co. Ltd. | Gastric antacid and method for controlling pH of gastric juice |
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB9319732D0 (en) * | 1993-09-24 | 1993-11-10 | Ucb Sa | Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety |
RO121085B1 (ro) * | 1999-12-01 | 2006-12-29 | Ucb, S.A., | Utilizarea levetiracetamului, în tratamentul bolilor sistemului nervos central |
US20040116506A1 (en) * | 2002-06-20 | 2004-06-17 | Krusz John Claude | Use of levetiracetam for treating or preventing acute headaches |
CN1205938C (zh) * | 2002-10-08 | 2005-06-15 | 深圳海王药业有限公司 | 具有改善哺乳动物微循环作用的产品 |
WO2004069796A2 (en) * | 2003-02-03 | 2004-08-19 | Teva Pharmaceutical Industries Ltd. | Process for producing levetiracetam |
AU2003217438A1 (en) * | 2003-03-18 | 2004-10-11 | Hetero Drugs Limited | Novel crystalline forms of levetiracetam |
EP1663968A1 (de) * | 2003-09-05 | 2006-06-07 | Ranbaxy Laboratories Limited | Verfahren zur herstellung von reinem levetiracetam |
CA2581831C (en) | 2005-07-26 | 2013-11-12 | Ucb Pharma, S.A. | Pharmaceutical compositions comprising levetiracetam and process for their preparation |
-
2006
- 2006-03-07 AT AT06251210T patent/ATE413875T1/de not_active IP Right Cessation
- 2006-03-07 US US11/371,128 patent/US20070172521A1/en not_active Abandoned
- 2006-03-07 CA CA002637925A patent/CA2637925A1/en not_active Abandoned
- 2006-03-07 PT PT06251210T patent/PT1810676E/pt unknown
- 2006-03-07 DK DK06251210T patent/DK1810676T3/da active
- 2006-03-07 ES ES06251210T patent/ES2317452T3/es active Active
- 2006-03-07 WO PCT/US2006/008298 patent/WO2007086891A1/en active Application Filing
- 2006-03-07 EP EP06251210A patent/EP1810676B1/de not_active Revoked
- 2006-03-07 PL PL06251210T patent/PL1810676T3/pl unknown
- 2006-03-07 CN CNA2006800516061A patent/CN101360493A/zh active Pending
- 2006-03-07 JP JP2008552284A patent/JP2009524658A/ja active Pending
- 2006-03-07 DE DE602006003617T patent/DE602006003617D1/de active Active
-
2008
- 2008-07-24 IL IL193024A patent/IL193024A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL193024A0 (en) | 2009-02-11 |
EP1810676B1 (de) | 2008-11-12 |
DK1810676T3 (da) | 2009-02-09 |
ES2317452T3 (es) | 2009-04-16 |
JP2009524658A (ja) | 2009-07-02 |
CA2637925A1 (en) | 2007-08-02 |
CN101360493A (zh) | 2009-02-04 |
PL1810676T3 (pl) | 2009-04-30 |
EP1810676A1 (de) | 2007-07-25 |
ATE413875T1 (de) | 2008-11-15 |
WO2007086891A1 (en) | 2007-08-02 |
US20070172521A1 (en) | 2007-07-26 |
PT1810676E (pt) | 2009-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006003617D1 (de) | Zusammensetzungen enthaltend Levetiracetam und Verfahren zu deren Herstellung. | |
ATE482194T1 (de) | Indolonderivate, verfahren zu deren herstellung und deren anwendungen | |
DE602006001312D1 (de) | Krystallinform gamma von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharamazeutische Zusammensetzung | |
DE602005015397D1 (de) | Leuchtstoff, Verfahren zu seiner Herstellung und diesen Leuchtstoff verwendende Lichtquelle | |
DE602006001411D1 (de) | Kristallinform gamma-d von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharmazeutische Zusammensetzung | |
DE602006002624D1 (de) | Krystallinform beta von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharamazeutische Zusammensetzung | |
DE602006001365D1 (de) | Kristallinform beta-d von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharmazeutische Zusammensetzung | |
DE602005023877D1 (de) | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide | |
DE602008000786D1 (de) | 1,2,4,5-Tetrahydro-3H-Benzazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
DE602006015062D1 (de) | 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
ATE502024T1 (de) | Diosmetin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
CY1112960T1 (el) | Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων | |
SE0401762D0 (sv) | Novel compounds | |
UA95253C2 (ru) | Соединения аналога камптотецина, способ их получения и фармацевтическая композиция, которая их содержит | |
DE602008005648D1 (de) | Tonerzusammensetzungen, Verfahren zu dessen Herstellung und Bilderzeugungsvorrichtung | |
DE602006000102D1 (de) | Indanyl-piperazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
ATE462408T1 (de) | Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung | |
DE602006018172D1 (de) | Cyclische n-ä1,3,4ü-thiadiazol-2-yl-benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
EA200701688A1 (ru) | Замещённые пирролы, содержащие их композиции, способ получения и применение | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
ATE405550T1 (de) | Polysubstituierte 1,1- pyridinyloxycyclopropanamine derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen | |
MY144748A (en) | Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them | |
DE102006033187A8 (de) | Pulverförmiges Gelatineprodukt und Verfahren zu dessen Herstellung | |
ATE483709T1 (de) | Beta-carbolinarylsulfonamide, verfahren zu ihrer herstellung und zusammensetzung, die sie enthält |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |